Connect with us

NEWS

October’s €6 Billion Drop Hides a Market That Kept Writing Cheques

European tech funding fell 62 per cent to €6 billion in October, but 288 deals still closed after September’s mega-rounds left the room.

Published

on

European tech startups raised €6 billion across 288 deals in October 2026, down 62 per cent from September’s €15.8 billion even as deal count slipped only 4 per cent. Twelve fewer rounds closed, 25 nine-figure cheques shrank to 10, and the month looks like a crash only if September is treated as normal.

September’s €15.8 Billion Set an Unrepeatable Bar

September was the spike. Companies raised €15.8 billion across 300 deals after August’s €3.2 billion across 165, and three rounds cleared €1 billion. French AI lab Mistral took €3 billion in a Series D at a post-money valuation of more than €21 billion, and London’s Nscale added two financings, one of about $3 billion and another of $3.36 billion. Twenty-five companies raised more than €100 million each, the ten largest deals absorbed 70.8 per cent of the month, and cloud led with €5.5 billion, 35 per cent of the pot, while the UK alone took €7.3 billion across 65 transactions.

SEPTEMBER VERSUS OCTOBER

Month Total raised Deals Rounds above €100 million UK haul UK deals Exits
September 2026 €15.8 billion 300 25 €7.3 billion 65 39
October 2026 €6 billion 288 10 €2.6 billion 75 39

Lift those billion-euro prints out of the comparison and October reads as a working month with smaller average cheques, not as a shutters-down winter. Dealroom’s tracker of European venture through 7 October already had companies on course for about $88 billion in 2026, with rounds of $100 million or more accounting for $41 billion, more than the $27 billion those large rounds raised in all of 2025. A year earlier, October 2025 itself came in at €8.3 billion across 342 deals, so this October is also softer than last year’s, not only softer than September.

Ten Cheques Still Cleared Nine Figures

Out of 288 October deals, 10 companies still raised more than €100 million each, and the value of 42 rounds was not disclosed. The monthly tally logged British AI chipmaker Fractile as the largest, on Companies House paper of £577.4 million. The other public nine-figure names sat in health, legal software, fintech debt and photonics, which is a thinner cast than September’s 25 but not an empty one.

THE PUBLIC NINE-FIGURE NAMES

  • Fractile: £577.4 million of Series C shares allotted in London, the month’s largest filing.
  • ID Finance: A €545 million debt and equity package out of Spain.
  • Legora: A $550 million round that took the Stockholm legal AI company to $8.8 billion, another chapter in the thin rebound that still hangs on mega-rounds.
  • CMR Surgical: About £301.9 million of preferred equity in Cambridge.
  • OMass Therapeutics: About £233.8 million Series C in Oxford.
  • Salience Labs: £125 million Series B in Cambridge for silicon photonics.

Those six do not pretend to be the full set of 10. They are the ones in plain view, and they already show how much of an “average” month is still a handful of names.

Cambridge and Oxford Carried the Healthtech Month

The October tally put healthtech first by investment volume. The public evidence for that claim sits in the Oxford-Cambridge corridor, because the monthly sector cell published with the report still carries a September label and a figure that does not add up, so it is no use as a Europe-wide total.

In the week of 12 to 16 October, UK companies raised £877.6 million across 26 deals, the heaviest British week of the month. Cambridge surgical robotics firm CMR Surgical took about £301.9 million of preferred equity from Stryker, which also secured an option to acquire the company. Oxford’s OMass Therapeutics raised about £233.8 million in a Series C for its protein-structure drug platform. Those two health cheques alone came to more than £535 million.

Beside them, Salience Labs raised £125 million for photonic chips, a deep-tech round that travelled with the corridor money without being a health deal. Smaller health cheques kept landing through the rest of the month, from microbiome drugs to glucose sensors, which is how a sector can lead a €6 billion month even when the single largest filing is an AI chip company.

The Chip Round Landed in the Filings First

Fractile, founded in 2022 by Walter Goodwin after an Oxford robotics doctorate, with Yuhang Song as co-founder, designs inference chips that keep memory next to the transistors doing the sums. The company says some long AI jobs now run at about 40 tokens per second and take around a month, and it is aiming for 1,200 tokens per second, which would cut that month to a day. It has not shipped a production chip. Manufacture of the first product-scale part is due next year.

FRACTILE’S PATH TO THE ROUND

  1. July 2024: Emerges from stealth with a £12 million seed round.
  2. May 2026: Raises a $220 million Series B at a valuation of about $1 billion.
  3. 9 September to 23 October 2026: Allots £577.4 million of Series C shares at three prices, £801.54, £707.25 and £1,452.35, with the C-3 class bringing in £392.2 million.
  4. 11 November 2026: The company says it has raised $720 million; the UK government says the round is worth over £500 million and values the firm at over £5 billion.

The £577.4 million is the cash on nine Series C share allotment returns for company 14143636, filed on 15 and 28 October, covering allotments from 9 September to 23 October. The $720 million is what Fractile itself announced on 11 November, led by Thrive Capital, Founders Fund, Lightspeed and Redpoint. The government’s “over £500 million” is a floor in official language, not a third independent total.

Fractile had already licensed a RISC-V vector processor as it built the part. Its own account of the product is blunt: the first product-scale chip, due to be manufactured next year, will stack DRAM directly on top of the processor. Talks have put an initial Anthropic order at about $250 million of those chips, for delivery in 2027.

For too long, Britain has produced some of the world’s best scientific ideas, only to see too much of the technology, industry and wealth they create built elsewhere. We are determined to change that.

Kanishka Narayan, AI Minister, 11 November government statement

Sovereign AI and the British Business Bank joined the round. The government did not disclose their cheques, and its own notes put typical Sovereign AI equity tickets at about £1 million to £10 million. Business Secretary Jonathan Reynolds called Fractile a “fantastic British success story” and said the fundraising would boost Britain’s ability to make AI chips at home. The same statement values the company at over £5 billion.

A $720 million Series C on a 2027 ship date prices scarcity, a compiler stack and a customer slot. It does not price a warehouse of working parts. That gap is the whole bet, and it is also why a monthly total that still uses the October filings as its largest deal can sit one day after a company announcement that is already in dollars and north of the paper.

Britain Wrote More Cheques for Less Money

The UK remained Europe’s largest fundraising market in October, at €2.6 billion across 75 transactions. That is 43 per cent of the money and 26 per cent of the deals. A month earlier Britain took €7.3 billion across 65 deals. Deal count in the UK rose by 10 while the euros shrank, which is the national version of the continental story: more founders got a cheque, fewer got a giant one.

London still produced most of the deal flow. Cambridge produced the two heaviest healthcare and photonics prints. Oxford produced OMass. Fractile itself is a London and Bristol company, which is why a month that “belongs” to healthtech on the tally can still be pulled around by a chip filing from the same country.

Thirty-Nine Sales, Same as September

Exit activity stayed at 39 transactions, matching September exactly. In September, Germany led with eight exits, about 21 per cent of the total, with France on six and the UK and Sweden on three each. October’s country split was not published with the monthly tally.

The 288 October deals are the part of the month that does not need a mega-round to exist. Fractile’s first product-scale chip is due to be manufactured in 2027. Until that silicon exists, Europe’s monthly totals will keep leaping whenever a name the size of Mistral, Nscale or Fractile prints, then dropping the month after, while the rest of the cheque book stays open.

Disclaimer: This article is news reporting on published funding totals, company announcements and official statements, and it is informational only. It is not investment advice, a solicitation, or a recommendation to buy or sell any security or to back any private company named here. Readers considering an allocation to venture funds or private tech shares should consult a qualified financial adviser who can review their circumstances. Figures and round sizes reflect the filings, company statements and monthly tallies cited, and later revisions, currency moves or undisclosed tranches can change them.

Harry is the editor of IAQABA, an independent publication he owns and runs. A decade in journalism, beginning as a reporter and now as the editor of his own titles, has left him with a clear test for what deserves a story: it has to change what a reader knows or decides, and it has to rest on something he can point to. That rules out recycled press releases, forecasts with no data behind them and rumours that no document supports. It leaves room for a great deal, and the site covers news, business, science and technology alongside sports, entertainment and lifestyle, with travel, auto and gaming given the same standard rather than lighter treatment. Sources are primary wherever possible: the regulator's filing, the company's own statement, the transcript, the dataset, or the product on Harry's desk. Figures are checked before they are published and rechecked if a reader questions them. Mistakes are corrected under a published policy. Readers across the world can reach him directly at support@iaqaba.com.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending